Lindbrook Capital’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$65.2K Buy
106
+97
+1,078% +$55.1K 0.01% 877
2024
Q4
$4.77K Sell
9
-7
-44% -$3.95K ﹤0.01% 2005
2024
Q3
$9.62K Buy
16
+1
+7% +$567 ﹤0.01% 1700
2024
Q2
$8.14K Sell
15
-5
-25% -$2.86K ﹤0.01% 1745
2024
Q1
$12.8K Sell
20
-5
-20% -$3.04K ﹤0.01% 1430
2023
Q4
$14.6K Buy
25
+20
+400% +$11.2K ﹤0.01% 1343
2023
Q3
$2.6K Sell
5
-6
-55% -$3.12K ﹤0.01% 2031
2023
Q2
$5.96K Buy
11
+1
+10% +$547 ﹤0.01% 1716
2023
Q1
$5.38K Buy
10
+8
+400% +$4.08K ﹤0.01% 1824
2022
Q4
$1.02K Sell
2
-2
-50% -$974 ﹤0.01% 2460
2022
Q3
$2K Sell
4
-2
-33% -$962 ﹤0.01% 2016
2022
Q2
$3K Sell
6
-3
-33% -$1.46K ﹤0.01% 1758
2022
Q1
$5K Hold
9
﹤0.01% 1577
2021
Q4
$5K Buy
9
+5
+125% +$2.4K ﹤0.01% 1496
2021
Q3
$2K Hold
4
﹤0.01% 1513
2021
Q2
$2K Sell
4
-2
-33% -$960 ﹤0.01% 1566
2021
Q1
$3K Buy
6
+5
+500% +$2.45K ﹤0.01% 1401
2020
Q4
$1K Buy
+1
New +$491 ﹤0.01% 1590

Other funds holding CHE

Lindbrook Capital's CHE Position: Q1 2025 in Review

Lindbrook Capital increased its Chemed (CHE) stake by 1,078% in Q1 2025, buying an estimated $55.1K and bringing the position to 106 shares worth $65.2K. The position accounts for 0.01% of the portfolio, ranked #877.

Lindbrook Capital first reported a position in CHE in Q4 2020 and has held it in 18 quarters since. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Lindbrook Capital held 106 shares of Chemed worth $65.2K as of Q1 2025.
  • Lindbrook Capital bought 97 Chemed shares in Q1 2025, an estimated $55.1K.
  • Chemed made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #877 holding.
  • Lindbrook Capital first reported a position in Chemed in Q4 2020 and has held it in 18 quarters since.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.